Global Functional Flow Reserve Market
Global Functional Flow Reserve Market

Functional Flow Reserve Comprehensive Study by Type (FFR Guidewires Systems, FFR Monitoring Systems), Application (Single-vessel Diseases, Multi-vessel Disease), Measurement (2D, 3D), End Users (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), Disease (Cardiology, Coronary Artery Disease), Technology (Invasive Monitoring, Non-invasive Monitoring) Players and Region - Global Market Outlook to 2025

Functional Flow Reserve Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025 | CAGR: 15.65%  

Oct 2020 Edition 232 Pages 215 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Functional Flow Reserve Market?

Fractional flow reserve is a technique used in coronary catheterization to measure pressure differences across a coronary artery stenosis to determine the possibility of the stenosis impeding delivery of oxygen to the heart muscle. According to a secondary source, about 370,000 people died due to coronary artery disease in the U.S. Moreover, the increasing aged population of over 60 years are more prone to cardiac diseases. As per an association survey of 2018, over 92 million U.S. adults are having cardiovascular disease or after-effects of stroke. Hence, the widening base of geriatric population is supporting the market growth. According to a secondary source, about 18 million people die globally due to cardiovascular diseases. In addition, the increasing number of diabetes with various associated risks such as the accumulation of fatty cells in coronary arteries are major reasons for the blockage. This will increase the demand for fractional flow reserve in the coming years.

The market study is being classified by Type (FFR Guidewires Systems and FFR Monitoring Systems), by Application (Single-vessel Diseases and Multi-vessel Disease) and major geographies with country level break-up. According to AMA, the Global Functional Flow Reserve market is expected to see growth rate of 15.65%

Abbott (United States), Boston Scientific (United States), Opsens (Canada), ACIST Medical Systems (United States), Koninklijke Philips N.V. (Netherlands), HeartFlow, Inc. (US), Siemens Healthineers (Germany), Pie Medical Imaging (Netherlands), CathWorks (Israel), Medis Medical Imaging Systems BV (Netherlands), GE Healthcare (United States) and Pulse Medical Imaging Technology (China) are some of the key players profiled in the study.

Research Analyst at AMA predicts that United States and European Players will contribute to the maximum growth of Global Functional Flow Reserve market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Functional Flow Reserve market by Type, Application and Region. On the basis of Type, FFR Guidewires Systems are dominating the market in the year 2019 where as FFR Monitoring Systems stood as second largest market share.

On the basis of application, Multi-vessel Disease segment is dominating the market in the year 2019 where as Single-vessel Diseases segment stood as second largest market.

On the basis of geography, the market of Functional Flow Reserve has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2019. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Prevalence Of Cardiovascular Diseases
  • Rising Geriatric Population
  • Escalating Costs are Driving Attention Toward Value-Based Healthcare

Market Trend
  • Rising Number Of Clinical Trials And Regulatory Approvals
  • Trend For Quantitative Flow Ratio (QFR)

Restraints
  • Reluctance to Adopt FFR by Cardiologists

Opportunities
  • Growth Potential In Emerging Economies
  • Increasingly Focusing On R&D On Developing FFR Techniques
  • Rising Number Of Clinical Trials And Regulatory Approvals

Challenges
  • Technical Limitations FFR


In March 2019, Abbott's Resting Full-cycle Ratio (RFR) intravascular diagnostic test received the United States FDA approval. This is a new type of fractional flow reserve (FFR) coronary lesion assessment technology. It assesses the heart at rest while avoiding vasodilators


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Functional Flow Reserve Manufacturer, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End Use Industry

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • FFR Guidewires Systems
  • FFR Monitoring Systems
By Application
  • Single-vessel Diseases
  • Multi-vessel Disease
By Measurement
  • 2D
  • 3D

By End Users
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers

By Disease
  • Cardiology
  • Coronary Artery Disease

By Technology
  • Invasive Monitoring
  • Non-invasive Monitoring

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence Of Cardiovascular Diseases
      • 3.2.2. Rising Geriatric Population
      • 3.2.3. Escalating Costs are Driving Attention Toward Value-Based Healthcare
    • 3.3. Market Challenges
      • 3.3.1. Technical Limitations FFR
    • 3.4. Market Trends
      • 3.4.1. Rising Number Of Clinical Trials And Regulatory Approvals
      • 3.4.2. Trend For Quantitative Flow Ratio (QFR)
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Functional Flow Reserve, by Type, Application, Measurement, End Users, Disease, Technology and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Functional Flow Reserve (Value)
      • 5.2.1. Global Functional Flow Reserve by: Type (Value)
        • 5.2.1.1. FFR Guidewires Systems
        • 5.2.1.2. FFR Monitoring Systems
      • 5.2.2. Global Functional Flow Reserve by: Application (Value)
        • 5.2.2.1. Single-vessel Diseases
        • 5.2.2.2. Multi-vessel Disease
      • 5.2.3. Global Functional Flow Reserve by: Measurement (Value)
        • 5.2.3.1. 2D
        • 5.2.3.2. 3D
      • 5.2.4. Global Functional Flow Reserve by: End Users (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Diagnostic Centers
        • 5.2.4.3. Ambulatory Surgical Centers
      • 5.2.5. Global Functional Flow Reserve by: Disease (Value)
        • 5.2.5.1. Cardiology
        • 5.2.5.2. Coronary Artery Disease
      • 5.2.6. Global Functional Flow Reserve by: Technology (Value)
        • 5.2.6.1. Invasive Monitoring
        • 5.2.6.2. Non-invasive Monitoring
      • 5.2.7. Global Functional Flow Reserve Region
        • 5.2.7.1. South America
          • 5.2.7.1.1. Brazil
          • 5.2.7.1.2. Argentina
          • 5.2.7.1.3. Rest of South America
        • 5.2.7.2. Asia Pacific
          • 5.2.7.2.1. China
          • 5.2.7.2.2. Japan
          • 5.2.7.2.3. India
          • 5.2.7.2.4. South Korea
          • 5.2.7.2.5. Taiwan
          • 5.2.7.2.6. Australia
          • 5.2.7.2.7. Rest of Asia-Pacific
        • 5.2.7.3. Europe
          • 5.2.7.3.1. Germany
          • 5.2.7.3.2. France
          • 5.2.7.3.3. Italy
          • 5.2.7.3.4. United Kingdom
          • 5.2.7.3.5. Netherlands
          • 5.2.7.3.6. Rest of Europe
        • 5.2.7.4. MEA
          • 5.2.7.4.1. Middle East
          • 5.2.7.4.2. Africa
        • 5.2.7.5. North America
          • 5.2.7.5.1. United States
          • 5.2.7.5.2. Canada
          • 5.2.7.5.3. Mexico
  • 6. Functional Flow Reserve: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Opsens (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. ACIST Medical Systems (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Koninklijke Philips N.V. (Netherlands)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. HeartFlow, Inc. (US)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Siemens Healthineers (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Pie Medical Imaging (Netherlands)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. CathWorks (Israel)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Medis Medical Imaging Systems BV (Netherlands)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. GE Healthcare (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Pulse Medical Imaging Technology (China)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Functional Flow Reserve Sale, by Type, Application, Measurement, End Users, Disease, Technology and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Functional Flow Reserve (Value)
      • 7.2.1. Global Functional Flow Reserve by: Type (Value)
        • 7.2.1.1. FFR Guidewires Systems
        • 7.2.1.2. FFR Monitoring Systems
      • 7.2.2. Global Functional Flow Reserve by: Application (Value)
        • 7.2.2.1. Single-vessel Diseases
        • 7.2.2.2. Multi-vessel Disease
      • 7.2.3. Global Functional Flow Reserve by: Measurement (Value)
        • 7.2.3.1. 2D
        • 7.2.3.2. 3D
      • 7.2.4. Global Functional Flow Reserve by: End Users (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Diagnostic Centers
        • 7.2.4.3. Ambulatory Surgical Centers
      • 7.2.5. Global Functional Flow Reserve by: Disease (Value)
        • 7.2.5.1. Cardiology
        • 7.2.5.2. Coronary Artery Disease
      • 7.2.6. Global Functional Flow Reserve by: Technology (Value)
        • 7.2.6.1. Invasive Monitoring
        • 7.2.6.2. Non-invasive Monitoring
      • 7.2.7. Global Functional Flow Reserve Region
        • 7.2.7.1. South America
          • 7.2.7.1.1. Brazil
          • 7.2.7.1.2. Argentina
          • 7.2.7.1.3. Rest of South America
        • 7.2.7.2. Asia Pacific
          • 7.2.7.2.1. China
          • 7.2.7.2.2. Japan
          • 7.2.7.2.3. India
          • 7.2.7.2.4. South Korea
          • 7.2.7.2.5. Taiwan
          • 7.2.7.2.6. Australia
          • 7.2.7.2.7. Rest of Asia-Pacific
        • 7.2.7.3. Europe
          • 7.2.7.3.1. Germany
          • 7.2.7.3.2. France
          • 7.2.7.3.3. Italy
          • 7.2.7.3.4. United Kingdom
          • 7.2.7.3.5. Netherlands
          • 7.2.7.3.6. Rest of Europe
        • 7.2.7.4. MEA
          • 7.2.7.4.1. Middle East
          • 7.2.7.4.2. Africa
        • 7.2.7.5. North America
          • 7.2.7.5.1. United States
          • 7.2.7.5.2. Canada
          • 7.2.7.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Functional Flow Reserve: by Type(USD Million)
  • Table 2. Functional Flow Reserve FFR Guidewires Systems , by Region USD Million (2014-2019)
  • Table 3. Functional Flow Reserve FFR Monitoring Systems , by Region USD Million (2014-2019)
  • Table 4. Functional Flow Reserve: by Application(USD Million)
  • Table 5. Functional Flow Reserve Single-vessel Diseases , by Region USD Million (2014-2019)
  • Table 6. Functional Flow Reserve Multi-vessel Disease , by Region USD Million (2014-2019)
  • Table 7. Functional Flow Reserve: by Measurement(USD Million)
  • Table 8. Functional Flow Reserve 2D , by Region USD Million (2014-2019)
  • Table 9. Functional Flow Reserve 3D , by Region USD Million (2014-2019)
  • Table 10. Functional Flow Reserve: by End Users(USD Million)
  • Table 11. Functional Flow Reserve Hospitals , by Region USD Million (2014-2019)
  • Table 12. Functional Flow Reserve Diagnostic Centers , by Region USD Million (2014-2019)
  • Table 13. Functional Flow Reserve Ambulatory Surgical Centers , by Region USD Million (2014-2019)
  • Table 14. Functional Flow Reserve: by Disease(USD Million)
  • Table 15. Functional Flow Reserve Cardiology , by Region USD Million (2014-2019)
  • Table 16. Functional Flow Reserve Coronary Artery Disease , by Region USD Million (2014-2019)
  • Table 17. Functional Flow Reserve: by Technology(USD Million)
  • Table 18. Functional Flow Reserve Invasive Monitoring , by Region USD Million (2014-2019)
  • Table 19. Functional Flow Reserve Non-invasive Monitoring , by Region USD Million (2014-2019)
  • Table 20. South America Functional Flow Reserve, by Country USD Million (2014-2019)
  • Table 21. South America Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 22. South America Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 23. South America Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 24. South America Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 25. South America Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 26. South America Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 27. Brazil Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 28. Brazil Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 29. Brazil Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 30. Brazil Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 31. Brazil Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 32. Brazil Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 33. Argentina Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 34. Argentina Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 35. Argentina Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 36. Argentina Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 37. Argentina Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 38. Argentina Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 39. Rest of South America Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 40. Rest of South America Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 41. Rest of South America Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 42. Rest of South America Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 43. Rest of South America Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 44. Rest of South America Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 45. Asia Pacific Functional Flow Reserve, by Country USD Million (2014-2019)
  • Table 46. Asia Pacific Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 47. Asia Pacific Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 48. Asia Pacific Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 49. Asia Pacific Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 50. Asia Pacific Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 51. Asia Pacific Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 52. China Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 53. China Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 54. China Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 55. China Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 56. China Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 57. China Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 58. Japan Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 59. Japan Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 60. Japan Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 61. Japan Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 62. Japan Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 63. Japan Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 64. India Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 65. India Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 66. India Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 67. India Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 68. India Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 69. India Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 70. South Korea Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 71. South Korea Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 72. South Korea Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 73. South Korea Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 74. South Korea Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 75. South Korea Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 76. Taiwan Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 77. Taiwan Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 78. Taiwan Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 79. Taiwan Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 80. Taiwan Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 81. Taiwan Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 82. Australia Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 83. Australia Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 84. Australia Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 85. Australia Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 86. Australia Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 87. Australia Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 88. Rest of Asia-Pacific Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 89. Rest of Asia-Pacific Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 90. Rest of Asia-Pacific Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 91. Rest of Asia-Pacific Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 92. Rest of Asia-Pacific Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 93. Rest of Asia-Pacific Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 94. Europe Functional Flow Reserve, by Country USD Million (2014-2019)
  • Table 95. Europe Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 96. Europe Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 97. Europe Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 98. Europe Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 99. Europe Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 100. Europe Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 101. Germany Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 102. Germany Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 103. Germany Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 104. Germany Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 105. Germany Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 106. Germany Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 107. France Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 108. France Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 109. France Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 110. France Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 111. France Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 112. France Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 113. Italy Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 114. Italy Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 115. Italy Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 116. Italy Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 117. Italy Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 118. Italy Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 119. United Kingdom Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 120. United Kingdom Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 121. United Kingdom Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 122. United Kingdom Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 123. United Kingdom Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 124. United Kingdom Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 125. Netherlands Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 126. Netherlands Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 127. Netherlands Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 128. Netherlands Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 129. Netherlands Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 130. Netherlands Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 131. Rest of Europe Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 132. Rest of Europe Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 133. Rest of Europe Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 134. Rest of Europe Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 135. Rest of Europe Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 136. Rest of Europe Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 137. MEA Functional Flow Reserve, by Country USD Million (2014-2019)
  • Table 138. MEA Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 139. MEA Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 140. MEA Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 141. MEA Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 142. MEA Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 143. MEA Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 144. Middle East Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 145. Middle East Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 146. Middle East Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 147. Middle East Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 148. Middle East Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 149. Middle East Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 150. Africa Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 151. Africa Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 152. Africa Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 153. Africa Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 154. Africa Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 155. Africa Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 156. North America Functional Flow Reserve, by Country USD Million (2014-2019)
  • Table 157. North America Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 158. North America Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 159. North America Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 160. North America Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 161. North America Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 162. North America Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 163. United States Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 164. United States Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 165. United States Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 166. United States Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 167. United States Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 168. United States Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 169. Canada Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 170. Canada Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 171. Canada Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 172. Canada Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 173. Canada Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 174. Canada Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 175. Mexico Functional Flow Reserve, by Type USD Million (2014-2019)
  • Table 176. Mexico Functional Flow Reserve, by Application USD Million (2014-2019)
  • Table 177. Mexico Functional Flow Reserve, by Measurement USD Million (2014-2019)
  • Table 178. Mexico Functional Flow Reserve, by End Users USD Million (2014-2019)
  • Table 179. Mexico Functional Flow Reserve, by Disease USD Million (2014-2019)
  • Table 180. Mexico Functional Flow Reserve, by Technology USD Million (2014-2019)
  • Table 181. Company Basic Information, Sales Area and Its Competitors
  • Table 182. Company Basic Information, Sales Area and Its Competitors
  • Table 183. Company Basic Information, Sales Area and Its Competitors
  • Table 184. Company Basic Information, Sales Area and Its Competitors
  • Table 185. Company Basic Information, Sales Area and Its Competitors
  • Table 186. Company Basic Information, Sales Area and Its Competitors
  • Table 187. Company Basic Information, Sales Area and Its Competitors
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Functional Flow Reserve: by Type(USD Million)
  • Table 194. Functional Flow Reserve FFR Guidewires Systems , by Region USD Million (2020-2025)
  • Table 195. Functional Flow Reserve FFR Monitoring Systems , by Region USD Million (2020-2025)
  • Table 196. Functional Flow Reserve: by Application(USD Million)
  • Table 197. Functional Flow Reserve Single-vessel Diseases , by Region USD Million (2020-2025)
  • Table 198. Functional Flow Reserve Multi-vessel Disease , by Region USD Million (2020-2025)
  • Table 199. Functional Flow Reserve: by Measurement(USD Million)
  • Table 200. Functional Flow Reserve 2D , by Region USD Million (2020-2025)
  • Table 201. Functional Flow Reserve 3D , by Region USD Million (2020-2025)
  • Table 202. Functional Flow Reserve: by End Users(USD Million)
  • Table 203. Functional Flow Reserve Hospitals , by Region USD Million (2020-2025)
  • Table 204. Functional Flow Reserve Diagnostic Centers , by Region USD Million (2020-2025)
  • Table 205. Functional Flow Reserve Ambulatory Surgical Centers , by Region USD Million (2020-2025)
  • Table 206. Functional Flow Reserve: by Disease(USD Million)
  • Table 207. Functional Flow Reserve Cardiology , by Region USD Million (2020-2025)
  • Table 208. Functional Flow Reserve Coronary Artery Disease , by Region USD Million (2020-2025)
  • Table 209. Functional Flow Reserve: by Technology(USD Million)
  • Table 210. Functional Flow Reserve Invasive Monitoring , by Region USD Million (2020-2025)
  • Table 211. Functional Flow Reserve Non-invasive Monitoring , by Region USD Million (2020-2025)
  • Table 212. South America Functional Flow Reserve, by Country USD Million (2020-2025)
  • Table 213. South America Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 214. South America Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 215. South America Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 216. South America Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 217. South America Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 218. South America Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 219. Brazil Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 220. Brazil Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 221. Brazil Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 222. Brazil Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 223. Brazil Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 224. Brazil Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 225. Argentina Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 226. Argentina Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 227. Argentina Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 228. Argentina Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 229. Argentina Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 230. Argentina Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 231. Rest of South America Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 232. Rest of South America Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 233. Rest of South America Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 234. Rest of South America Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 235. Rest of South America Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 236. Rest of South America Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 237. Asia Pacific Functional Flow Reserve, by Country USD Million (2020-2025)
  • Table 238. Asia Pacific Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 239. Asia Pacific Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 240. Asia Pacific Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 241. Asia Pacific Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 242. Asia Pacific Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 243. Asia Pacific Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 244. China Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 245. China Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 246. China Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 247. China Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 248. China Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 249. China Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 250. Japan Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 251. Japan Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 252. Japan Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 253. Japan Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 254. Japan Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 255. Japan Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 256. India Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 257. India Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 258. India Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 259. India Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 260. India Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 261. India Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 262. South Korea Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 263. South Korea Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 264. South Korea Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 265. South Korea Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 266. South Korea Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 267. South Korea Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 268. Taiwan Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 269. Taiwan Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 270. Taiwan Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 271. Taiwan Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 272. Taiwan Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 273. Taiwan Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 274. Australia Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 275. Australia Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 276. Australia Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 277. Australia Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 278. Australia Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 279. Australia Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 280. Rest of Asia-Pacific Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 281. Rest of Asia-Pacific Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 282. Rest of Asia-Pacific Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 283. Rest of Asia-Pacific Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 284. Rest of Asia-Pacific Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 285. Rest of Asia-Pacific Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 286. Europe Functional Flow Reserve, by Country USD Million (2020-2025)
  • Table 287. Europe Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 288. Europe Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 289. Europe Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 290. Europe Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 291. Europe Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 292. Europe Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 293. Germany Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 294. Germany Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 295. Germany Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 296. Germany Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 297. Germany Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 298. Germany Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 299. France Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 300. France Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 301. France Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 302. France Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 303. France Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 304. France Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 305. Italy Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 306. Italy Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 307. Italy Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 308. Italy Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 309. Italy Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 310. Italy Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 311. United Kingdom Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 312. United Kingdom Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 313. United Kingdom Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 314. United Kingdom Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 315. United Kingdom Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 316. United Kingdom Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 317. Netherlands Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 318. Netherlands Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 319. Netherlands Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 320. Netherlands Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 321. Netherlands Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 322. Netherlands Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 323. Rest of Europe Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 324. Rest of Europe Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 325. Rest of Europe Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 326. Rest of Europe Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 327. Rest of Europe Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 328. Rest of Europe Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 329. MEA Functional Flow Reserve, by Country USD Million (2020-2025)
  • Table 330. MEA Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 331. MEA Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 332. MEA Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 333. MEA Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 334. MEA Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 335. MEA Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 336. Middle East Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 337. Middle East Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 338. Middle East Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 339. Middle East Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 340. Middle East Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 341. Middle East Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 342. Africa Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 343. Africa Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 344. Africa Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 345. Africa Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 346. Africa Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 347. Africa Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 348. North America Functional Flow Reserve, by Country USD Million (2020-2025)
  • Table 349. North America Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 350. North America Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 351. North America Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 352. North America Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 353. North America Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 354. North America Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 355. United States Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 356. United States Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 357. United States Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 358. United States Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 359. United States Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 360. United States Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 361. Canada Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 362. Canada Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 363. Canada Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 364. Canada Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 365. Canada Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 366. Canada Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 367. Mexico Functional Flow Reserve, by Type USD Million (2020-2025)
  • Table 368. Mexico Functional Flow Reserve, by Application USD Million (2020-2025)
  • Table 369. Mexico Functional Flow Reserve, by Measurement USD Million (2020-2025)
  • Table 370. Mexico Functional Flow Reserve, by End Users USD Million (2020-2025)
  • Table 371. Mexico Functional Flow Reserve, by Disease USD Million (2020-2025)
  • Table 372. Mexico Functional Flow Reserve, by Technology USD Million (2020-2025)
  • Table 373. Research Programs/Design for This Report
  • Table 374. Key Data Information from Secondary Sources
  • Table 375. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Functional Flow Reserve: by Type USD Million (2014-2019)
  • Figure 5. Global Functional Flow Reserve: by Application USD Million (2014-2019)
  • Figure 6. Global Functional Flow Reserve: by Measurement USD Million (2014-2019)
  • Figure 7. Global Functional Flow Reserve: by End Users USD Million (2014-2019)
  • Figure 8. Global Functional Flow Reserve: by Disease USD Million (2014-2019)
  • Figure 9. Global Functional Flow Reserve: by Technology USD Million (2014-2019)
  • Figure 10. South America Functional Flow Reserve Share (%), by Country
  • Figure 11. Asia Pacific Functional Flow Reserve Share (%), by Country
  • Figure 12. Europe Functional Flow Reserve Share (%), by Country
  • Figure 13. MEA Functional Flow Reserve Share (%), by Country
  • Figure 14. North America Functional Flow Reserve Share (%), by Country
  • Figure 15. Global Functional Flow Reserve share by Players 2019 (%)
  • Figure 16. Global Functional Flow Reserve share by Players (Top 3) 2019(%)
  • Figure 17. Global Functional Flow Reserve share by Players (Top 5) 2019(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 20. Abbott (United States) Revenue: by Geography 2019
  • Figure 21. Boston Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 22. Boston Scientific (United States) Revenue: by Geography 2019
  • Figure 23. Opsens (Canada) Revenue, Net Income and Gross profit
  • Figure 24. Opsens (Canada) Revenue: by Geography 2019
  • Figure 25. ACIST Medical Systems (United States) Revenue, Net Income and Gross profit
  • Figure 26. ACIST Medical Systems (United States) Revenue: by Geography 2019
  • Figure 27. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 28. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2019
  • Figure 29. HeartFlow, Inc. (US) Revenue, Net Income and Gross profit
  • Figure 30. HeartFlow, Inc. (US) Revenue: by Geography 2019
  • Figure 31. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Siemens Healthineers (Germany) Revenue: by Geography 2019
  • Figure 33. Pie Medical Imaging (Netherlands) Revenue, Net Income and Gross profit
  • Figure 34. Pie Medical Imaging (Netherlands) Revenue: by Geography 2019
  • Figure 35. CathWorks (Israel) Revenue, Net Income and Gross profit
  • Figure 36. CathWorks (Israel) Revenue: by Geography 2019
  • Figure 37. Medis Medical Imaging Systems BV (Netherlands) Revenue, Net Income and Gross profit
  • Figure 38. Medis Medical Imaging Systems BV (Netherlands) Revenue: by Geography 2019
  • Figure 39. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 40. GE Healthcare (United States) Revenue: by Geography 2019
  • Figure 41. Pulse Medical Imaging Technology (China) Revenue, Net Income and Gross profit
  • Figure 42. Pulse Medical Imaging Technology (China) Revenue: by Geography 2019
  • Figure 43. Global Functional Flow Reserve: by Type USD Million (2020-2025)
  • Figure 44. Global Functional Flow Reserve: by Application USD Million (2020-2025)
  • Figure 45. Global Functional Flow Reserve: by Measurement USD Million (2020-2025)
  • Figure 46. Global Functional Flow Reserve: by End Users USD Million (2020-2025)
  • Figure 47. Global Functional Flow Reserve: by Disease USD Million (2020-2025)
  • Figure 48. Global Functional Flow Reserve: by Technology USD Million (2020-2025)
  • Figure 49. South America Functional Flow Reserve Share (%), by Country
  • Figure 50. Asia Pacific Functional Flow Reserve Share (%), by Country
  • Figure 51. Europe Functional Flow Reserve Share (%), by Country
  • Figure 52. MEA Functional Flow Reserve Share (%), by Country
  • Figure 53. North America Functional Flow Reserve Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Abbott (United States)
  • Boston Scientific (United States)
  • Opsens (Canada)
  • ACIST Medical Systems (United States)
  • Koninklijke Philips N.V. (Netherlands)
  • HeartFlow, Inc. (US)
  • Siemens Healthineers (Germany)
  • Pie Medical Imaging (Netherlands)
  • CathWorks (Israel)
  • Medis Medical Imaging Systems BV (Netherlands)
  • GE Healthcare (United States)
  • Pulse Medical Imaging Technology (China)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation